Zevra - ADHS - A Star is born (Seite 4)
eröffnet am 06.09.21 11:06:47 von
neuester Beitrag 29.04.24 23:28:00 von
neuester Beitrag 29.04.24 23:28:00 von
Beiträge: 41
ID: 1.352.190
ID: 1.352.190
Aufrufe heute: 0
Gesamt: 4.148
Gesamt: 4.148
Aktive User: 0
ISIN: US4884452065 · WKN: A2QLX7 · Symbol: ZVRA
4,8200
USD
-4,17 %
-0,2100 USD
Letzter Kurs 11.05.24 Nasdaq
Neuigkeiten
09.05.24 · globenewswire  |
08.05.24 · globenewswire |
01.05.24 · globenewswire |
29.04.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 8,8800 | +57,45 | |
| 17,440 | +44,61 | |
| 1,9750 | +27,42 | |
| 1,8400 | +26,03 | |
| 4,9500 | +25,32 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 10,965 | -18,48 | |
| 0,7845 | -19,36 | |
| 3,3200 | -22,61 | |
| 0,6785 | -26,19 | |
| 3,3100 | -77,44 |
Beitrag zu dieser Diskussion schreiben
Feedback
KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program
Mon, December 20, 2021,
CELEBRATION, Fla., Dec. 20, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today its Board of Directors has authorized a program to repurchase up to $50 million of the Company’s outstanding stock. The share repurchase authorization is effective immediately and valid through December 31, 2023. This program is equivalent to approximately 18 percent of KemPharm’s current market capitalization.
KemPharm: Who We Are
Congrats to @KemPharmInc on winning the #BioFL2021 Company of the Year award! KemPharm has received FDA approval on a truly differentiating ADHD drug. We look forward to continuing to see this company’s success as they develop new and innovative treatments.
https://twitter.com/BioFlorida/status/1469304159539245060
https://twitter.com/BioFlorida/status/1469304159539245060
Aufrufe heute: 0 
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
Wed, November 10, 2021, 10:05 PM
Corporate and Regulatory Highlights
Appointment of Richard W. Pascoe as Executive Chairman; Mr. Pascoe to focus on executing the Company’s strategic growth plans
Uplisted to The Nasdaq Global Select Market
Research involving AZSTARYS® and serdexmethylphenidate featured in poster presentations at multiple medical conferences during ADHD Awareness Month (October)
Data presented during the 2021 Virtual International Conference on ADHD affirmed AZSTARYS’ 30-minute onset of action and 13-hour duration of effect
Appointed Tamara A. Seymour to Board of Directors
U.S. commercial launch of AZSTARYS initiated on July 21, 2021
Financial Highlights
Q3 2021 net loss of $0.05 per basic share
Reported Q3 2021 revenue of $2.0 million
Total cash and cash equivalents was $131.5 million at September 30, 2021
https://finance.yahoo.com/news/kempharm-reports-third-quarte…
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
Wed, November 10, 2021, 10:05 PM
Corporate and Regulatory Highlights
Appointment of Richard W. Pascoe as Executive Chairman; Mr. Pascoe to focus on executing the Company’s strategic growth plans
Uplisted to The Nasdaq Global Select Market
Research involving AZSTARYS® and serdexmethylphenidate featured in poster presentations at multiple medical conferences during ADHD Awareness Month (October)
Data presented during the 2021 Virtual International Conference on ADHD affirmed AZSTARYS’ 30-minute onset of action and 13-hour duration of effect
Appointed Tamara A. Seymour to Board of Directors
U.S. commercial launch of AZSTARYS initiated on July 21, 2021
Financial Highlights
Q3 2021 net loss of $0.05 per basic share
Reported Q3 2021 revenue of $2.0 million
Total cash and cash equivalents was $131.5 million at September 30, 2021
https://finance.yahoo.com/news/kempharm-reports-third-quarte…
Sehr gute Erfahrungsberichte der ersten Anwender - freut mich auch und insbesondere für die betroffenen Kinder, Eltern und Lehrer. Azstarys works 
"Yes, not really seeing any negatives yet. Her teacher made a comment to mom today, that she was very attentive today. She had no knowledge of her treatment. I also notice more communication w me and mom verbally and visually. Its been wonderful. Im still trying not to get to excited though. Fingers crossed"
"My son took his first dose today. As I was dropping him off to school today, he said, “Dad, I’m really excited for school today.” Already a winner in my book."
"So my daughter is also Autistic (luckily very mild ASD)
Day 2 her appetite is great. Definite improvement from what the norm was. I am amazed at how much attention she has while doing homework or even watching cartoons. We just did not see these things with other treatments. Awesome".
https://stocktwits.com/alanls1/message/387141793
"Yes, not really seeing any negatives yet. Her teacher made a comment to mom today, that she was very attentive today. She had no knowledge of her treatment. I also notice more communication w me and mom verbally and visually. Its been wonderful. Im still trying not to get to excited though. Fingers crossed"
"My son took his first dose today. As I was dropping him off to school today, he said, “Dad, I’m really excited for school today.” Already a winner in my book."
"So my daughter is also Autistic (luckily very mild ASD)
Day 2 her appetite is great. Definite improvement from what the norm was. I am amazed at how much attention she has while doing homework or even watching cartoons. We just did not see these things with other treatments. Awesome".
https://stocktwits.com/alanls1/message/387141793
Trading Spotlight
Antwort auf Beitrag Nr.: 69.439.360 von flyingbeef am 27.09.21 23:31:59
So schauts aus
Gerne auch ein paar Dollar in prominente Markenbotschafter investieren, da gibts etliche mit ADHS von denen man es nicht gedacht hätte. Wusste es nur von Bubba Watson.
War für mich eigentlich immer so eine Vorschul/ Grundschul Geschichte, eh ich mich näher mit KemPharm beschäftigt hatte
Famous People with ADHD
https://addadult.com/add-education-center/famous-people-with…
Zitat von flyingbeef: Corium erhält Finanzspritze für Vermarktung, News Heute sollte einiges an Zuversicht bringen das alle Beteiligten es ernst meinen und bald auch etwas mehr Speed bei Vermarktung aufgenommen werden kann.
So schauts aus
Gerne auch ein paar Dollar in prominente Markenbotschafter investieren, da gibts etliche mit ADHS von denen man es nicht gedacht hätte. Wusste es nur von Bubba Watson.
War für mich eigentlich immer so eine Vorschul/ Grundschul Geschichte, eh ich mich näher mit KemPharm beschäftigt hatte
Famous People with ADHD
https://addadult.com/add-education-center/famous-people-with…
Corium erhält Finanzspritze für Vermarktung, News Heute sollte einiges an Zuversicht bringen das alle Beteiligten es ernst meinen und bald auch etwas mehr Speed bei Vermarktung aufgenommen werden kann.
Antwort auf Beitrag Nr.: 69.411.392 von soulist am 23.09.21 21:34:35"Message to shareholders: ALL UPSIDE FROM HERE"
Travis Mickle, CEO KemPharm Answers ALL Viewer Questions On $KMPH Company and the Future! 23.09.2021
The Clinical Research Circle
The Clinical Research Circle
Die ersten Erfahrungsberichte trudeln ein und sind durchweg positiv, auch insbesondere im direkten Vergleich zum bisherigen Topseller Vyvanse
Takeda meldete bislang einen Nettoumsatz von 203 Milliarden Yen (1,83 Milliarden US-Dollar) für Vyvanse innerhalb der letzten zwei Jahre (2020/2021).
Patentschutz von Vyvanse bis 2023 (Takeda)
Patentschutz von Asztarys bis 2037
https://stocktwits.com/X2020/message/377675835
Comments & ratings on the side effects, benefits, and effectiveness of Azstarys Oral.
Dan | 19-24 | Male | On medication for less than 1 month | Caregiver
9/7/2021
My son has been through 3 ADHD meds before Azstarys. Concerta and Focalin were a disaster for him with horrible mood swings. Adderal was the most tolerable for him but it totally wreaks his appetite and disrupts his sleep. Azstarys has been incredible with a steady effectiveness for the entire day into the late evening. He doesn’t get the roller coaster mood swings and Azstarys hasn’t caused him to lose his appetite. So far Azstarys has been a game changer for him without al the negative side effects that came along with the other treatments. We are so happy our son can get the benefits of focusing on his work and studies without all negative effects like the other treatments cause.
Nick | 7-12 | Male | On medication for less than 1 month | Caregiver
9/6/2021
Azstarys was my kids 4th drug. He is 10. The other 3 had too many side effects. One was on the amphetamine side and the other 2 were methylphenidate. On one he never ate. On another he had a tough time sleeping at night. The third one didn't work for him. It's been about 2 weeks on Azstarys and it seems so far to be working great. It works. And he isn't getting the major unwanted side effects. I would highly recommend this to any parent who is having issues with the drug their kid is on..
...
https://www.webmd.com/drugs/drugreview-181842-azstarys-oral
DoctorAcula
Bullish $KMPH
Future #1 ADHD drug is NOW AVAILABLE and initial patient reviews indicate how much better this is then Vyvanse, the current leader.
Takeda meldete bislang einen Nettoumsatz von 203 Milliarden Yen (1,83 Milliarden US-Dollar) für Vyvanse innerhalb der letzten zwei Jahre (2020/2021).
Patentschutz von Vyvanse bis 2023 (Takeda)
Patentschutz von Asztarys bis 2037
https://stocktwits.com/X2020/message/377675835
Comments & ratings on the side effects, benefits, and effectiveness of Azstarys Oral.
Dan | 19-24 | Male | On medication for less than 1 month | Caregiver
9/7/2021
My son has been through 3 ADHD meds before Azstarys. Concerta and Focalin were a disaster for him with horrible mood swings. Adderal was the most tolerable for him but it totally wreaks his appetite and disrupts his sleep. Azstarys has been incredible with a steady effectiveness for the entire day into the late evening. He doesn’t get the roller coaster mood swings and Azstarys hasn’t caused him to lose his appetite. So far Azstarys has been a game changer for him without al the negative side effects that came along with the other treatments. We are so happy our son can get the benefits of focusing on his work and studies without all negative effects like the other treatments cause.
Nick | 7-12 | Male | On medication for less than 1 month | Caregiver
9/6/2021
Azstarys was my kids 4th drug. He is 10. The other 3 had too many side effects. One was on the amphetamine side and the other 2 were methylphenidate. On one he never ate. On another he had a tough time sleeping at night. The third one didn't work for him. It's been about 2 weeks on Azstarys and it seems so far to be working great. It works. And he isn't getting the major unwanted side effects. I would highly recommend this to any parent who is having issues with the drug their kid is on..
...
https://www.webmd.com/drugs/drugreview-181842-azstarys-oral
DoctorAcula
Bullish $KMPH
Future #1 ADHD drug is NOW AVAILABLE and initial patient reviews indicate how much better this is then Vyvanse, the current leader.
Durchsuchen
Zevra - ADHS - A Star is born
